Attenuation of miR-17∼92 Cluster in Bronchopulmonary Dysplasia.

RATIONALE Bronchopulmonary dysplasia remains a significant cause of neonatal morbidity; however, the identification of novel targets to predict or prevent the development of bronchopulmonary dysplasia remains elusive. Proper microRNA (miR)-17∼92 cluster is necessary for normal lung development, and alterations in expression are reported in other pulmonary diseases. The overall hypothesis for our work is that altered miR-17∼92 cluster expression contributes to the molecular pathogenesis of bronchopulmonary dysplasia. OBJECTIVES The current studies tested the hypothesis that alterations in miR-17∼92 cluster and DNA methyltransferase expression are present in bronchopulmonary dysplasia. METHODS miR-17∼92 cluster expression, promoter methylation, and DNA methyltransferase expression were determined in autopsy lung samples obtained from premature infants who died with bronchopulmonary dysplasia, or from term/near-term infants who died from nonrespiratory causes. Expression of miR-17∼92 cluster members miR-17 and -19b was measured in plasma samples collected in the first week of life from a separate cohort of preterm infants at a second institution in whom bronchopulmonary dysplasia was diagnosed subsequently. MEASUREMENTS AND MAIN RESULTS Autopsy tissue data indicated that miR-17∼92 expression is significantly lower in bronchopulmonary dysplasia lungs and is inversely correlated with promoter methylation and DNA methyltransferase expression when compared with that of control subjects without bronchopulmonary dysplasia. Plasma sample analyses indicated that miR-17 and -19b expression was decreased in infants who subsequently developed bronchopulmonary dysplasia. CONCLUSIONS Our data are the first to demonstrate altered expression of the miR-17∼92 cluster in bronchopulmonary dysplasia. The consistency between our autopsy and plasma findings further support our working hypothesis that the miR-17∼92 cluster contributes to the molecular pathogenesis of bronchopulmonary dysplasia.

[1]  S. Bhattacharya,et al.  Alterations in gene expression and DNA methylation during murine and human lung alveolar septation. , 2014, American journal of respiratory cell and molecular biology.

[2]  B. Thébaud,et al.  Lung mesenchymal stromal cells in development and disease: to serve and protect? , 2014, Antioxidants & redox signaling.

[3]  R. Strasser,et al.  Regulation of the Hif-system by micro-RNA 17 and 20a - role during monocyte-to-macrophage differentiation. , 2013, Molecular immunology.

[4]  L. Rogers,et al.  Associations between Maternal and Infant Morbidities and sRAGE within the First Week of Life in Extremely Preterm Infants , 2013, PloS one.

[5]  J. Byrd,et al.  Detection of extracellular RNAs in cancer and viral infection via tethered cationic lipoplex nanoparticles containing molecular beacons. , 2013, Analytical chemistry.

[6]  Q. Kan,et al.  MicroRNA expression profiling studies on bronchopulmonary dysplasia: a systematic review and meta-analysis. , 2013, Genetics and molecular research : GMR.

[7]  S. Zhang,et al.  Reduction of MicroRNA-206 Contributes to the Development of Bronchopulmonary Dysplasia through Up-Regulation of Fibronectin 1 , 2013, PloS one.

[8]  S. Jeng,et al.  MicroRNA Expression Aberration Associated with Bronchopulmonary Dysplasia in Preterm Infants: A Preliminary Study , 2013, Respiratory Care.

[9]  Carmen Z. Cantemir-Stone,et al.  Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.

[10]  S. Volinia,et al.  Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples , 2012, Modern Pathology.

[11]  S. Bhattacharya,et al.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. , 2012, American journal of respiratory and critical care medicine.

[12]  M. Pennell,et al.  Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia , 2012, Acta paediatrica.

[13]  Anna Ochałek,et al.  Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR-17-92 axis , 2012, The EMBO journal.

[14]  B. Shi,et al.  MiR‐17‐92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells , 2012, Journal of cellular biochemistry.

[15]  K. Cherubini,et al.  The role of epigenetic transcription repression and DNA methyltransferases in cancer , 2011, Cancer.

[16]  L. J. Lee,et al.  Formation and finite element analysis of tethered bilayer lipid structures. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[17]  E. Bancalari,et al.  Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. , 2010, American journal of respiratory cell and molecular biology.

[18]  L. V. Marter.  Epidemiology of bronchopulmonary dysplasia. , 2009 .

[19]  O. Eickelberg,et al.  Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. , 2009 .

[20]  Stefanie Dimmeler,et al.  The microRNA-17~92 cluster: Still a miRacle? , 2009, Cell cycle.

[21]  Min Hee Kim,et al.  Epidemiology of Bronchopulmonary Dysplasia in Korea: Multi-Center Study , 2009 .

[22]  S. P. Nana-Sinkam,et al.  Lung microRNA: from development to disease , 2009, Expert review of respiratory medicine.

[23]  V. Bhandari,et al.  Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia , 2009, Pediatrics.

[24]  Yun Lu,et al.  Epithelial progenitor cells of the embryonic lung and the role of microRNAs in their proliferation. , 2008, Proceedings of the American Thoracic Society.

[25]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[26]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[27]  B. Thébaud,et al.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. , 2007, American journal of respiratory and critical care medicine.

[28]  S. Archer,et al.  Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization , 2005, Circulation.

[29]  G. Pryhuber,et al.  Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans. , 2005, American journal of respiratory and critical care medicine.

[30]  齊藤 三佳.  Mitogenic activity of tracheal effluents from premature infants with chronic lung disease , 2005 .

[31]  W. Carlo,et al.  Bronchopulmonary dysplasia: new insights. , 2004, Clinics in perinatology.

[32]  B. Stripp,et al.  Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways. , 2002, American journal of respiratory and critical care medicine.

[33]  M. O’Reilly,et al.  Increased epithelial cell proliferation in very premature baboons with chronic lung disease. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[34]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[35]  D. Warburton,et al.  Bioactive Transforming Growth Factor-Beta in the Lungs of Extremely Low Birthweight Neonates Predicts the Need for Home Oxygen Supplementation , 2000, Neonatology.

[36]  M. O’Reilly,et al.  Tumor Necrosis Factor- α –Induced Lung Cell Expression of Antiapoptotic Genes TRAF1 and cIAP2 , 2000 .

[37]  M. O’Reilly,et al.  Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2. , 2000, American journal of respiratory cell and molecular biology.

[38]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[39]  M. Silverman,et al.  Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. , 1996, The Journal of pediatrics.

[40]  James Paton,et al.  Respiratory health in a total very low birthweight cohort and their classroom controls. , 1996, Archives of disease in childhood.